David Greenspan’s Tvardi Therapeutics TVRD Stock Holding History
Bought
Maintained
Sold
Other funds holding TVRD
David Greenspan's TVRD Position: Q3 2026 in Review
David Greenspan held its Tvardi Therapeutics (TVRD) position steady in Q3 2026 at 704,118 shares worth $880K. The position accounts for 0.01% of the portfolio, ranked #43.
David Greenspan first reported a position in TVRD in Q2 2025 and has held it in 6 quarters since. The position peaked at $27.4M in Q3 2025. 62 funds tracked by Wall St. Rank hold TVRD as of Q3 2026.
- David Greenspan held 704,118 shares of Tvardi Therapeutics worth $880K as of Q3 2026.
- David Greenspan left its Tvardi Therapeutics share count unchanged in Q3 2026.
- Tvardi Therapeutics made up 0.01% of David Greenspan's portfolio in Q3 2026, its #43 holding.
- David Greenspan first reported a position in Tvardi Therapeutics in Q2 2025 and has held it in 6 quarters since.
- David Greenspan's Tvardi Therapeutics position peaked at $27.4M in Q3 2025.
- 62 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q3 2026.
Based on Slate Path Capital's 13F filing for Q3 2026, filed 16 Nov 2026.